$INV

Innventure, Inc. (INV): Results of Operations and Financial Condition

Innventure, Inc. (INV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a991innventure-2q26earning.htm EX-99.1 Document Exhibit 99.1 Innventure Reports Second Quarter 2026 Results Accelsius focused on execution against foundational milestones to strengthen path to scaled two-phase adoption ORLANDO, Fla., August 13, 2026 (GLOBAL NEWSWIRE) –

Original reporting
Published Aug 13, 2026, 8:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$INV
Bearish
medium confidence
Mentioned
$INV
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$INVBearishMed
01

Why it matters

Management suspended previously communicated 2026 revenue and cash flow targets for Accelsius, citing evolving AI infrastructure market dynamics and constraints affecting smaller early adopters’ power availability, GPU access, and deployment timing.

02

Market read

Guidance suspension is the primary market-relevant signal, likely resetting expectations for 2026 cash generation tied to scaled adoption milestones.

03

What to watch

The excerpt does not include the actual 2Q financial figures or updated milestone timelines, so traders may overreact until the full EX-99.1 tables and call Q&A clarify cash runway and milestone probability.

Relevance 7/10Novelty 6/10Timing: after-hours today, ahead of the 5:00 pm ET conference call

Background

This is an SEC Form 8-K (Item 2.02) with an attached earnings release for Innventure’s quarter ended June 30, 2026, focused on its Accelsius two-phase liquid cooling thesis.

Company-level read

Ticker impact

$INVBearishMedium confidence
Context

Innventure reports 2Q 2026 results and suspends previously communicated 2026 revenue and cash flow targets for its Accelsius business.

Expected impact

Near-term downside bias versus prior expectations, with volatility around the 5:00 pm ET earnings call and any follow-on milestone updates.

Evidence & confidence

The filing is a fresh 8-K with a specific decision to suspend 2026 revenue and cash flow targets, which typically resets investor expectations even without new numeric guidance in the excerpt.

Market effects

Highlights uncertainty in near-term adoption timing for two-phase liquid cooling tied to AI infrastructure constraints, which can affect sentiment toward thermal management/AI infrastructure supply chains.

Limited direct regional read-through; primarily impacts US-listed small/mid-cap industrial growth narrative.

Two-phase liquid cooling demand framing is global, but the disclosed impact is company-specific and guidance-related.

Counterpoint

Suspending targets may reflect conservatism rather than deterioration, since management says long-term conviction strengthened and points to momentum at AeroFlexx and Refinity.

Key entities

  • Innventure, Inc.

    NASDAQ-listed industrial growth conglomerate reporting 2Q 2026 results and suspending 2026 Accelsius revenue and cash flow targets.

  • Accelsius

    Innventure’s two-phase liquid cooling initiative whose 2026 targets were suspended due to changing adoption dynamics.

Related articles

$INVMed

Placing and Offer for Subscription

The Board of The Investment Company plc (LSE: INV) published a circular to shareholders on 4 June 2026 outlining proposals for the company’s future. Plans include appointing Dowgate Wealth Limited as portfolio manager, adopting a new scarcity/resilience-focused investment policy, raising funds via a placing and offer for subscription, and providing a 100% exit option for qualifying shareholders not wishing to stay. Proposals require shareholder approval.

$INVMedAI 9/10

Innventure (INV) Q4 2025 Earnings Transcript

Innventure (INV) reported 2025 revenue of $2.1m vs. $1.2m in 2024, driven by Accelsius and AeroFlexx. Accelsius delivered $1.6m revenue (vs. $0.3m) and secured $50m+ in new Q1 bookings; Accelsius Series B closed at a ~$665m post-money valuation. Management expects Accelsius to be cash-flow positive by year-end. Cash rose to $65.4m; adjusted EBITDA loss was $78.8m.

$GSKMed

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

GSK plc reported Q2 results on July 28. Total turnover was £8.4bn, up 5% CER. Core operating profit rose 7% CER to £2.80bn and Core EPS increased 9% CER to 50.5p, driven by Specialty Medicines and Vaccines. Total operating profit fell 75% CER due to a £1.3bn non-cash impairment after discontinuing camlipixant. GSK also outlined a 2026 Phase III acceleration plan and a £1.9bn annual cost-savings restructuring program.

$BFRIMedAI 8/10

Biofrontera Posts Strong Q2 2026 Results On 33% Revenue Growth

Biofrontera (BFRI) reported Q2 2026 net product revenue of $12.0M, up 32.9% from $9.0M, with gross margin rising to 80% from 71%. Net loss narrowed to $0.6M from $5.3M. For six months, revenue was $22.1M (+25.4%) and gross margin 80%. A PDUFA decision for Ameluz is expected Sept. 28, 2026.

$UPWKMedAI 8/10

Why Upwork (UPWK) Stock Is Nosediving

Upwork (UPWK) shares fell about 10% after the company reported Q2 results that beat estimates but issued weaker full-year revenue and EPS guidance. Analysts at Scotiabank and RBC cut price targets to $10 and $9 from $15 and $20, respectively, while keeping Sector Perform ratings. The stock is down sharply year to date amid AI and labor-market concerns.